Navigation Links
Generic Drugs: World Market Outlook 2011-2021
Date:11/2/2011

p>

Beijing MedPharm

Bioniche Pharma Holdings 

Blue Cross Blue Shield Association (BCBSA)

BMP Sunstone

Boehringer Ingelheim

Bristol-Myers Squibb

British Generics Manufacturers Association (BGMA)

Cangene Corporation

Celltrion

Centers for Medicare and Medicaid Services

Cephalon 

Chon Kun Dang

Cipla

Claris Lifesciences

CoGenesys

Congressional Budget Office (CBO)

Corporacion Infarmasa [Peru]

Daiichi Sankyo

Dey Pharma

DOC Generici

Dr. Reddy's Laboratories

Ebewe Pharma

Eden Biodesign 

Egis

Eisai Pharmaceuticals

Eli Lilly

EMS Sigma Pharma

Eon Labs

Eurofarma Laboratorios

European Commission (EC)

European Court of Justice

European Generic Medicines Association (EGA)

European Medicines Agency (EMA/EMEA)

European Union (EU)

Famy Care

Farmacia del Ahorro

Farmacias Similares

Federal Trade Commission (FTC)

Food and Drug Administration (US FDA)

Fuji Pharma

Gedeon Richter

Genentech

Generic Pharmaceutical Association (GPhA)

German Association of Pharmacists (ABDA)

GlaxoSmithKline (GSK)

Glenmark Pharmaceuticals

Greenstone (Pfizer)

Healthcare Economics LLC

H. Lundbeck

Hospira

Hospira Healthcare India 

Intas Biopharmaceuticals

IVAX

Javelin Pharmaceuticals 

Johnson & Johnson

Jubilant Organosys

Kowa Pharmaceuticals

Krka

Laboratorios Best

Laboratorios Kendrick

Lareq Pharma

Lek Pharmaceuticals

Lupin Pharmaceuticals

MasterLek

Matrix

Matrix Laboratories 

Mayne Pharma

Medi-Mart

Medley Pharmaceuticals

Merck & Co.

Merck KGaA

Ministry of H
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Multi-therapy Drugs: Opportunities for Generics & Biosimilars
2. Perrigo Announces Launch of Generic Version of Elestat®
3. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
4. Mylan Receives Approval for Generic Version of MS Contin® Tablets
5. FTC Study Finds that in FY 2011, Pharmaceutical Industry Continued to Make Numerous Business Deals that Delay Consumers Access to Lower-Cost Generic Drugs
6. INNOPHARMA Receives FDA Approval of Generic Olanzapine Injection
7. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
8. Par Pharmaceutical Begins Shipment of Generic Zyprexa® Zydis®
9. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
10. Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
11. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... July 14, 2014  Patients and patient advocates are ... Scripts and other major pharmacy benefit managers (PBMs) begin ... directly impact millions of patients who rely on compounded ... persistent pain from cancer, diabetes and other illnesses. Express ... patients on July 15. In a matter ...
(Date:7/14/2014)... WOONSOCKET, R.I. , July 14, 2014 /PRNewswire/ ... of radiance ®  PLATINUM, a premium brand ... latest addition to the growing family of exclusive ... 44 vitamins and supplements with various benefits, including ... for both men and women. The radiance PLATINUM line also ...
(Date:7/14/2014)... 2014 We are pleased to announce Orthopaedic ... Ellicott City Ambulatory Surgery Center ("EC") have merged and ... Maryland . The OACM/EC merger ... leading Orthopaedics, Sports Medicine, Hand, Spine, Pain, GYN, and ... specialties of general surgery and ophthalmology and will maintain ...
Breaking Medicine Technology:Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 2Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 3Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 4CVS/pharmacy Launches Exclusive radiance PLATINUM Line of Preservative-Free Vitamins and Supplements 2CVS/pharmacy Launches Exclusive radiance PLATINUM Line of Preservative-Free Vitamins and Supplements 3
... SOUTHAMPTON, England, June 29 Vantia ... drugs,targeting large, underserved medical markets, announces positive results ... development compound VA106483 for,nocturia. The trial showed that ... sustained anti-diuretic effect in patients, as determined by,increased ...
... England and TOKYO, June 29 , ... Sosei Group Corporation ("Sosei"; TSE Mothers ... commencement of a Phase III,clinical study by Novartis, with NVA237, ... obstructive pulmonary disease,(COPD). NVA237 is a dry powder formulation for ...
Cached Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4
(Date:7/14/2014)... 2014 Acute coronary syndrome (ACS) ... healthcare costs, frequent recurrences and hospitalizations, and high ... ACS incidence increases with age and will be ... population increases around the world. ACS is classified ... heart muscle damage inferred from a person’s symptoms, ...
(Date:7/14/2014)... 14, 2014 Georgia State University ... groups under the fifth round of its Second ... of research and academic performance. , The ... of top-notch faculty members to the university, with ... in areas of national significance. , “With the ...
(Date:7/14/2014)... through the bloodstream, homing in on a sheath ... and metastasize to other organs, scientists at The ... in Cancer Cell . , "This completely ... provides new potential avenues to predict and prevent ... M.D., professor of Gynecologic Oncology and Reproductive Medicine ...
(Date:7/14/2014)... look back on 40 years of the Glasgow Coma Scale ... and clinical practice, in a new Personal View published in ... Personal View is published on the 40th anniversary of the ... Since this seminal publication, the Glasgow Coma Scale has provided ... level, the clinical hallmark of acute brain injury. The scale ...
(Date:7/14/2014)... D.C., July 14, 2014 A recent study published ... of the American Academy of Child and Adolescent Psychiatry ... the age of onset criterion for diagnosis of attention-deficit/hyperactivity ... for ADHD, previously set at 7 in DSM-IV, has ... of onset is now set at 12, rather than ...
Breaking Medicine News(10 mins):Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 2Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 3Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 4Health News:Georgia State Starts Four Innovative Research Groups Through Fifth Round of Its Second Century Initiative 2Health News:Georgia State Starts Four Innovative Research Groups Through Fifth Round of Its Second Century Initiative 3Health News:MD Anderson researchers discover new route for ovarian cancer spread 2Health News:MD Anderson researchers discover new route for ovarian cancer spread 3
... , TAMPA, Fla. , Jan. ... the United States Preventative Task Force (USPTF), the Obesity Action ... add health insurance coverage of the recommended childhood obesity treatments. ... treating childhood obesity in moderate to intensive programs helps children ...
... , MORRISTOWN, N.J. , Jan. 19 ... a leading specialty pharmaceutical company, today confirmed that its subsidiary, ... (ANDA) with the U.S. Food and Drug Administration (FDA) seeking ... the expiration of U.S. Patent No. 5,827,529.  Watson,s lidocaine topical ...
... , Berk Prepares to Return as CEO , ... President Joel Seligman today announced that on March 1 ... full-time CEO of the Medical Center while Mark B. Taubman ... of Rochester School of Medicine and Dentistry .   , "I am excited ...
... will be held in Barcelona, Spain (Centre Convencions Internacional ... 24 - Saturday 27 March 2010. The ... the only one that involves all the major players ... between clinicians, scientists and patients in a partnership of ...
... survivors wait up to five years before disclosing they were ... Montral, the Universit du Qubec Montral and the Universit ... . "The number of victims who never reveal their ... very high," says co-author Mireille Cyr, a psychology professor of ...
... closely supported by a nurse-physician primary care team are twice ... those who receive usual care, according to a study by ... The research, published online in the latest edition of the ... 18 months of a randomized controlled trial, Guided Care recipients ...
Cached Medicine News:Health News:Obesity Action Coalition Calls on Insurers and Employers to Increase Access to Childhood Obesity Treatments Based on Recent United States Preventative Task Force Recommendations 2Health News:Watson Confirms Filing of FDA Application for Generic Lidoderm(R) 2Health News:Watson Confirms Filing of FDA Application for Generic Lidoderm(R) 3Health News:New Dean of School of Medicine and Dentistry Announced 2Health News:New Dean of School of Medicine and Dentistry Announced 3Health News:Disclosing sexual abuse is critical 2Health News:Guided Care participants rate quality of health care high 2